| 摘要 |
<p>The present invention relates to the novel drug delivery system using Tacrinequercetin conjugates for the treatment of Alzheimer's disease. The present invention also relates to the development of conjugate by a linker which could either be permanent that requires the Tacrine-quercetin conjugate to act as a delivery vector and active drug or is cleaved once inside the cell, thus releasing the active drugs. This novel conjugate prepared by click chemistry proves to be more effective in reducing the toxicity of tacrine and also for treating Alzheimer's.</p> |
